0001209191-20-014706.txt : 20200302
0001209191-20-014706.hdr.sgml : 20200302
20200302180536
ACCESSION NUMBER: 0001209191-20-014706
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200227
FILED AS OF DATE: 20200302
DATE AS OF CHANGE: 20200302
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Countouriotis Athena
CENTRAL INDEX KEY: 0001571469
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39231
FILM NUMBER: 20678838
MAIL ADDRESS:
STREET 1: C/O AMBIT BIOSCIENCES CORPORATION
STREET 2: 11080 ROSELLE STREET
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Passage BIO, Inc.
CENTRAL INDEX KEY: 0001787297
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 822729751
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: TWO COMMERCE SQUARE
STREET 2: 2001 MARKET STREET, 28TH FLOOR
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
BUSINESS PHONE: 2678660312
MAIL ADDRESS:
STREET 1: TWO COMMERCE SQUARE
STREET 2: 2001 MARKET STREET, 28TH FLOOR
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-02-27
0
0001787297
Passage BIO, Inc.
PASG
0001571469
Countouriotis Athena
TWO COMMERCE SQUARE
200 MARKET STREET, 28TH FLOOR
PHILADELPHIA
PA
19103
1
0
0
0
Director Stock Option (Right to Buy)
18.00
2020-02-27
4
A
0
33836
0.00
A
2030-02-27
Common Stock
33836
33836
D
The option vests as to 2.778% of the total shares monthly, commencing March 27, 2020, with 100% of the total shares vested on February 27, 2023, subject to the reporting person's provision of service to the issuer on each vesting date.
/s/ Richard Morris as attorney-in-fact for Athena Countouriotis
2020-03-02